China-based medical device company Mindray (SHE: 300760) has entered into a partnership with fellow Chinese firm Vazyme Biotech Co., Ltd. (SHA: 688105). The collaboration aims to develop a comprehensive automated solution for infection screening and respiratory pathogen detection.
Advancing Diagnostic Capabilities with Automation
The partnership will leverage the combined expertise of Mindray and Vazyme Biotech to create an automated solution that streamlines the testing process. This includes the “one tube blood” testing for blood routine, inflammation, and respiratory tract packages. The goal is to optimize the testing process, reduce work intensity, and enhance the quality of testing. By doing so, the partnership aims to provide more timely and comprehensive diagnostic and treatment information for clinical practice.
Vazyme Biotech’s Specialized R&D Focus
Vazyme Biotech is a company dedicated to the research and development of advanced technologies and products in the fields of enzymes, antigens, antibodies, and polymer organic materials. Their focus on innovation in these areas will be instrumental in the joint development of the automated diagnostic solutions.-Fineline Info & Tech
